Drug Testing Locations - Seward, AK

Drug Testing in Seward, AK

Seward, Alaska Statistics

In Seward, AK, located in Kenai Peninsula Borough, over 18% of young adults reported illicit drug use within the past month.

Seward, in Kenai Peninsula Borough, saw a 12% rise in opioid-related hospital admissions in the last year.

Methamphetamine use has increased by 15% in Seward, Kenai Peninsula Borough, over the past three years.

Seward, AK's drug overdose deaths rose by 25% since 2018, according to the Kenai Peninsula Borough Health Department.

Prescription drug misuse in Seward, AK accounts for 22% of all drug-related issues in Kenai Peninsula Borough.

The city of Seward reported 30 drug arrests in 2022, according to the Kenai Peninsula Borough's annual crime report.

How does the body eliminate Drugs

Drug elimination is the sum of the processes of removing an administered drug from the body. In the pharmacokinetic ADME scheme (absorption, distribution, metabolism, and excretion), it is frequently considered to encompass both metabolism and excretion. Hydrophobic drugs, to be excreted, must undergo metabolic modification making them more polar. Hydrophilic drugs, on the other hand, can undergo excretion directly, without the need for metabolic changes to their molecular structures.

Although many sites of metabolism and excretion exist, the chief organ of metabolism is the liver, while the organ primarily tasked with excretion is the kidney. Any significant dysfunction in either organ can result in the accumulation of the drug or its metabolites in toxic concentrations.

A variety of other factors impact elimination — intrinsic drug properties, such as polarity, size, or pKa. Also other factors include genetic variation among individuals, disease states affecting other organs, and pathways involved in the way the drug distributes through the body, such as first-pass metabolism.

Issues of Concern

Drug elimination is the removal of an administered drug from the body. It is accomplished in two ways, either by excretion of an unmetabolized drug in its intact form or by metabolic biotransformation followed by excretion. While excretion is primarily carried out by the kidneys, other organ systems are involved as well. Similarly, the liver is the primary site of biotransformation, yet extrahepatic metabolism takes place in a variety of organ systems affecting multiple drugs.

Given the multiple organ systems and the variety of metabolic transformations present, drug elimination can entail a significant degree of complexity. Hydrophilic drugs are typically directly excreted by the kidneys, while hydrophobic drugs undergo biotransformation before excretion. The purpose here is twofold – biotransformation serves both detoxify the exogenous substances as well as to increase their hydrophilicity, ensuring their elimination via the kidneys.

Two broad metabolic pathways of hepatic drug transformation exist. Phase I is the direct modification of the target molecule, whereas phase II entails conjugation of the target to a polar molecule of low molecular weight. Phase I prepare the drug to enter phase II, but single-phase metabolism also exists.

Phase I involves oxidation, reduction, and hydrolysis of the exogenous molecule. These reactions are accomplished by hepatic microsomal enzymes, which reside in the smooth endoplasmic reticulum of the hepatocytes. Best known among them is the cytochrome P450 system, whose enzymes are predominantly involved in oxidative metabolism. Within the cytochrome P450 family (CYP), the enzyme responsible for the metabolism of more than 50% of existing drugs is the CYP3A4. Its activity encompasses various classes of medications, including opioids, immunosuppressants, antihistamines, and benzodiazepines. The enzymes can also be induced or inhibited by a variety of substances they interact with, including pharmaceuticals. The increase in metabolic activity with CYP induction results in a diminished activity of drugs targeted by that particular isoform. Conversely, CYP inhibition will result in increased drug plasma concentration, potentially leading toxicity. The CYP3A4 is induced by phenytoin, phenobarbital, and St. John's wort, while diltiazem, erythromycin, and grapefruit inhibit it. Caution is, therefore, necessary when administering CYP3A4-metabolized drugs in the presence of any of the inhibitors or inducers.

Phase II consists of covalent bonding of polar groups to nonpolar molecules to render them water-soluble and allow renal or biliary excretion. Target molecules enter phase II directly or via initial processing through phase I. A variety of polar adjuncts is transferred, including amino acids, glucuronic acid, glutathione, acetate, and sulfate. Glucuronidation is one of the major pathways of phase II biotransformation. The UDP-glucuronosyltransferase (UGT) enzyme family performs this activity. Typically, glucuronide derivatives possess less or no activity of the original drug, but in some cases, pharmacologically active compounds result. Morphine-6-glucuronide is a phase II metabolite of morphine with significant analgesic activity. As with the CYP enzymes, inducers, and inhibitors of phase II, enzymes exist and may influence the efficacy of drugs that rely on conjugation before excretion.

The first-pass effect is a feature of hepatic metabolism that also plays a role in the elimination of multiple drugs. Here, the enteric consumed drugs are exposed directly to the liver via the portal vein, where they undergo biotransformation before entering the systemic circulation. This activity reduces the bioavailability and needs to be factored into the dose administered to the patient. Intravenously administered drugs are not subject to the first-pass effect.

Extrahepatic drug metabolism takes place in the GI tract, kidneys, lungs, plasma, and skin.

Renal excretion completes the process of elimination that begins in the liver. Polar drugs or their metabolites get filtered in the kidneys and typically do not undergo reabsorption. They subsequently get excreted in the urine. Urinary pH has a significant impact on excretion, as drug ionization changes depending on the alkaline or acidic environment. Increased excretion occurs with weakly acidic drugs in basic urine and weakly basic drugs in acidic urine.

Excretion in the bile is another significant form of drug elimination. The liver can actively secrete ionized drugs with a molecular weight greater than 300 g/mol into bile, from where they reach the digestive tract and are either eliminated in feces or reabsorbed as part of the enterohepatic cycle.

Other pathways of excretion include the lungs, breast milk, sweat, saliva, and tears

Employers in Seward, AK & Drug Testing Policies

Seward, AK, employers have implemented drug testing policies to ensure a safe work environment. These policies often include pre-employment screenings and random drug tests to deter substance abuse among employees. The State of Alaska provides guidelines for employers to maintain drug-free workplaces.

Local employers in Seward follow regulations and encourage drug-free environments by linking employees to support programs. Compliance with state and federal laws ensures that workplaces remain safe and productive, reinforcing the city’s commitment to combating drug issues.

Government Efforts with Drug Problems in Seward, AK

The government of Seward, AK, in Kenai Peninsula Borough, has launched various initiatives to combat drug abuse. The Seward Police Department, working alongside the Kenai Peninsula Borough, has increased community programs and outreach efforts focusing on education regarding the dangers of drug use.

State-level efforts also contribute, with programs led by the State of Alaska to support rehabilitation and recovery services. These government actions aim to reduce drug abuse through comprehensive educational campaigns and increased access to treatment facilities.

Local Drug Busts & News in Seward, AK

Seward, AK, witnessed several significant drug busts recently, reflecting the ongoing struggle against illicit substances in Kenai Peninsula Borough. These operations, often coordinated by the Seward Police Department and neighboring law enforcement agencies, aim to dismantle drug trafficking networks.

One of the largest busts in the recent year involved the recovery of substantial amounts of methamphetamine, highlighting the city's proactive stance to curb drug distribution. These events underscore the necessity of continued vigilance and community cooperation in addressing the drug problem.

Occupational Health Services

Accredited Drug Testing offers fast, reliable employment screening services in Seward, AK. Trusted by employers nationwide for accurate results and exceptional service.

Alaska DOT/Non DOT Physicals

Alaska Vision Tests

Alaska Audiograms

Alaska Respirator Fit Tests

Alaska Lift Tests

Alaska Background Checks

Clinical Testing Services

TB Testing in AK

Diabetes Testing in AK

Infectious Disease Testing in AK

Sickle Cell Anemia Testing in AK

Women/Men's Health Testing in AK

Resources & Citations

Alaska Department of Health and Social Services

Alaska Public Media

State of Alaska Website

Kenai Peninsula Borough

Alaska Substance Abuse Resources

Substance Abuse and Mental Health Services Administration

National Institute on Drug Abuse

Alaska State Office of Substance Abuse

Drug Testing Near Seward, AK

Port Ashton, AK

Silvertip, AK

Cooper Landing, AK

Moose Pass, AK

Crown Point, AK

Bear Creek, AK

Lowell Point, AK

Frequently Asked Questions

Customer Reviews